{
    "clinical_study": {
        "@rank": "66977", 
        "acronym": "MELAG", 
        "arm_group": {
            "arm_group_label": "Melatonin", 
            "arm_group_type": "Experimental", 
            "description": "melatonin 4mg od for 3 months"
        }, 
        "brief_summary": {
            "textblock": "The effect of 3 months of melatonin 4mg treatment on glucose tolerance in different variants\n      of the melatonin receptor 1B gene will be evaluated. The following will be done at 0 and 3\n      months:\n\n        -  OGTT\n\n        -  questionnaires about sleep and activity\n\n        -  Actigraph\n\n        -  Anthropometry\n\n        -  Blood pressure"
        }, 
        "brief_title": "Melatonin and Glucose Tolerance Among Individuals With a Variant of the MTNR1B Gene", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Diabetes", 
            "Glucose Tolerance"
        ], 
        "condition_browse": {
            "mesh_term": "Diabetes Mellitus"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  signed informed concent\n\n          -  Known genotype for MTNR1B from the Botnia-ppp study\n\n          -  Age 18-75 years\n\n        Exclusion Criteria:\n\n          -  Diabetes\n\n          -  Positive GAD-ab\n\n          -  Sever dysregulated hypertension\n\n          -  glaucoma\n\n          -  severe coronary heart disease or arrythmias\n\n          -  previous or ongoing severe ventricle or duodenal ulcer\n\n          -  psychosis or anxiety disorder\n\n          -  regular use of sleep pills, antidepressants or neuroleptics\n\n          -  creatinine > 130 \u00b5mol/L\n\n          -  elevated liver enzymes (ASAT, ALAT, ALP, GT, bilirubin) > 3 times reference value\n\n          -  inability to sign informed concent\n\n          -  other factor with according to the physician may affect treatment or results.\n\n          -  participation in other clinical study\n\n          -  allergy to melatonin or other substance in the capsule\n\n          -  hereditary galactose intolerance or glucose/galactose malabsorption\n\n          -  intention to become pregnant"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 10, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01705639", 
            "org_study_id": "EudraCT-2011-005360-22"
        }, 
        "intervention": {
            "arm_group_label": "Melatonin", 
            "description": "All subjects receive the same dose of melatonin", 
            "intervention_name": "Melatonin", 
            "intervention_type": "Drug", 
            "other_name": "Circadin"
        }, 
        "intervention_browse": {
            "mesh_term": "Melatonin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "diabetes", 
            "melatonin", 
            "glucose tolerance", 
            "sleep"
        ], 
        "lastchanged_date": "October 12, 2012", 
        "location": [
            {
                "contact": {
                    "email": "leena.saarelin@folkhalsan.fi", 
                    "last_name": "Leena Saarelin, nurse", 
                    "phone": "+358-6-7247"
                }, 
                "facility": {
                    "address": {
                        "city": "Jakobstad", 
                        "country": "Finland", 
                        "zip": "68660"
                    }, 
                    "name": "Botniacentret Jakobstad"
                }, 
                "investigator": {
                    "last_name": "Bo Isomaa, MD, Docent", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "britt.stolpe@vaasa.fi", 
                    "last_name": "Britt Stolpe, nurse", 
                    "phone": "+35863251732"
                }, 
                "facility": {
                    "address": {
                        "city": "Vasa", 
                        "country": "Finland", 
                        "zip": "65200"
                    }, 
                    "name": "Vasa health care centre"
                }, 
                "investigator": {
                    "last_name": "Johan S\u00f6derstr\u00f6m, MD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Finland"
        }, 
        "number_of_arms": "1", 
        "official_title": "Does Melatonin Treatment Affect Glucose Tolerance Among Individuals With a Variant (rs10830963) of the Melatonin Receptor 1B (MTNR1B) Gene?", 
        "overall_contact": {
            "email": "tom.forsen@helsinki.fi", 
            "last_name": "Tom Fors\u00e9n, MD, Docent", 
            "phone": "+358405203396"
        }, 
        "overall_official": [
            {
                "affiliation": "University of Lund, University of Helsinki", 
                "last_name": "Leif Groop, Prof.", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Helsinki University Hospital", 
                "last_name": "Tiinamaija Tuomi, Docent", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Folkhalsan", 
                "last_name": "Bo Isomaa, Docent", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Finland: Finnish Medicines Agency", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Glucose tolerance is measured in OGTT: 0,30,60,90 and 120 minute values of glucose and insulin.", 
            "measure": "Glucose tolerance", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01705639"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Helsinki University", 
            "investigator_full_name": "Tom Fors\u00e9n", 
            "investigator_title": "MD PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "monitoring of sleep with questionnaires and activity monitoring", 
                "measure": "sleep", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Activity and sleep of the subjects is recorded with Actigraph at 0 and 3 months", 
                "measure": "Activity", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }
        ], 
        "source": "Helsinki University", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Lund University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Vasa health care centre", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Folkhalsan", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Helsinki University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "October 2012"
    }
}